Seeking Alpha13/11/2026 08:20:00
Biostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027
Biostem outlines $10M-$12M annual cash opex cuts as it targets in-house manufacturing in H1 2027
31 min ago
Seeking Alpha
Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.